CL2014001983A1 - Composición de nitazoxanida; proceso para prepararla y sus usos como antiparasitarios. - Google Patents
Composición de nitazoxanida; proceso para prepararla y sus usos como antiparasitarios.Info
- Publication number
- CL2014001983A1 CL2014001983A1 CL2014001983A CL2014001983A CL2014001983A1 CL 2014001983 A1 CL2014001983 A1 CL 2014001983A1 CL 2014001983 A CL2014001983 A CL 2014001983A CL 2014001983 A CL2014001983 A CL 2014001983A CL 2014001983 A1 CL2014001983 A1 CL 2014001983A1
- Authority
- CL
- Chile
- Prior art keywords
- nitazoxanide
- antiparasitic
- prepare
- composition
- nitazoxanide composition
- Prior art date
Links
- YQNQNVDNTFHQSW-UHFFFAOYSA-N acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester Chemical compound CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N+]([O-])=O)S1 YQNQNVDNTFHQSW-UHFFFAOYSA-N 0.000 title 1
- 230000002141 anti-parasite Effects 0.000 title 1
- 239000003096 antiparasitic agent Substances 0.000 title 1
- 229960002480 nitazoxanide Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2012/050380 WO2013110975A1 (es) | 2012-01-27 | 2012-01-27 | Composición de nitazoxanida mejorada y proceso para prepararla |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014001983A1 true CL2014001983A1 (es) | 2015-03-06 |
Family
ID=48872931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014001983A CL2014001983A1 (es) | 2012-01-27 | 2014-07-25 | Composición de nitazoxanida; proceso para prepararla y sus usos como antiparasitarios. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9498441B2 (es) |
| EP (1) | EP2808019B1 (es) |
| AR (1) | AR089764A1 (es) |
| BR (1) | BR112014018149B1 (es) |
| CL (1) | CL2014001983A1 (es) |
| CR (1) | CR20140351A (es) |
| MX (1) | MX340846B (es) |
| NI (1) | NI201400082A (es) |
| UY (1) | UY34457A (es) |
| WO (1) | WO2013110975A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019241376A1 (en) | 2018-06-14 | 2019-12-19 | The Trustees Of Columbia University In The City Of New York | Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof |
| CN116983273A (zh) * | 2023-08-02 | 2023-11-03 | 海南慧谷药业有限公司 | 一种盐酸文拉法辛缓释制剂及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657267A (en) | 1969-06-20 | 1972-04-18 | Janssen Pharmaceutica Nv | Benzimidazole carbamates |
| GB1437800A (en) | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
| JPS517116A (en) * | 1974-06-11 | 1976-01-21 | Shinetsu Chemical Co | Choyoseihifukuyakuzaino seizohoho |
| US5387598A (en) | 1994-04-13 | 1995-02-07 | Rossignol; Jean-Francois | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
| US5968961A (en) | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
| CN100515420C (zh) | 1997-05-07 | 2009-07-22 | 罗马克实验室有限公司 | 脱乙酰基硝噻醋柳胺和硝噻醋柳胺的药用组合物 |
| US6132461A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
| US20040253323A1 (en) * | 2003-06-11 | 2004-12-16 | Giles Brian C. | Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis |
| US7618946B2 (en) * | 2003-11-27 | 2009-11-17 | Griffith University | Analgesic compounds, extracts containing same and methods of preparation |
| US20050171169A1 (en) | 2004-02-02 | 2005-08-04 | Rossignol Jean F. | Combination chemotherapy for helminth infections |
| US8007827B2 (en) * | 2004-04-02 | 2011-08-30 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| NZ597019A (en) * | 2005-12-23 | 2013-11-29 | Qbiotics Ltd | Tiglien-3-one derivatives |
| CA2636527C (en) | 2006-01-09 | 2016-05-17 | Romark Laboratories, L.C. | Viral hepatitis treatment |
| US20080299188A1 (en) | 2007-05-14 | 2008-12-04 | Pfizer Inc. | Controlled release dosage forms combining immediate release and sustainted release of low-solubility drug |
| MX339136B (es) | 2008-12-12 | 2016-05-13 | Rhein Siegfried Sa De Cv | Composicion de liberacion pulsatil de sildenafil y proceso para prepararla. |
| SI2395840T1 (sl) | 2009-02-13 | 2020-08-31 | Romark Laboratories, L.C. | Farmacevtske formulacije nitazoksanida z nadzorovanim sproščanjem |
-
2012
- 2012-01-27 WO PCT/IB2012/050380 patent/WO2013110975A1/es not_active Ceased
- 2012-01-27 BR BR112014018149-7A patent/BR112014018149B1/pt active IP Right Grant
- 2012-01-27 US US14/374,862 patent/US9498441B2/en active Active
- 2012-01-27 EP EP12866787.0A patent/EP2808019B1/en active Active
- 2012-01-27 MX MX2014008975A patent/MX340846B/es active IP Right Grant
- 2012-11-20 UY UY0001034457A patent/UY34457A/es active IP Right Grant
-
2013
- 2013-01-21 AR ARP130100172A patent/AR089764A1/es not_active Application Discontinuation
-
2014
- 2014-07-22 CR CR20140351A patent/CR20140351A/es unknown
- 2014-07-24 NI NI201400082A patent/NI201400082A/es unknown
- 2014-07-25 CL CL2014001983A patent/CL2014001983A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR089764A1 (es) | 2014-09-17 |
| US9498441B2 (en) | 2016-11-22 |
| BR112014018149B1 (pt) | 2020-09-29 |
| CR20140351A (es) | 2014-11-05 |
| EP2808019A1 (en) | 2014-12-03 |
| BR112014018149A2 (es) | 2017-06-20 |
| BR112014018149A8 (pt) | 2017-07-11 |
| EP2808019A4 (en) | 2015-06-10 |
| US20150064262A1 (en) | 2015-03-05 |
| MX2014008975A (es) | 2014-11-10 |
| EP2808019B1 (en) | 2019-09-25 |
| WO2013110975A1 (es) | 2013-08-01 |
| UY34457A (es) | 2013-09-02 |
| NI201400082A (es) | 2017-03-13 |
| MX340846B (es) | 2016-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6880072A2 (es) | Compuestos de n-tio-antranilamida y sus usos como plaguicidas | |
| CO7091189A2 (es) | Microemulsiones y sus usos como sistemas de administración | |
| SG11201603144QA (en) | Artificial nucleic acid molecules | |
| IL252379A0 (en) | Method of applying edge offset | |
| EP2862301A4 (en) | MULTICAST UNICAST CONVERSION METHOD | |
| CO6930353A2 (es) | Método para utilizar trazadores de liberación controlada | |
| PT2852671T (pt) | Produção de células ips humanas através de um rna autorreplicativo sintético | |
| SG10201607962RA (en) | Artificial nucleic acid molecules | |
| DK3777840T3 (da) | Rna-formulering til immunterapi | |
| EP2827905C0 (en) | STABILIZING COMPOSITION FOR BIOACTIVE MATERIALS | |
| CO6801802A2 (es) | Composición curable para usarse como material de circulación perdida | |
| CL2015001157A1 (es) | Composiciones y métodos para tratar proteinopatías. | |
| BR302012005543S1 (pt) | Configuração aplicada em recipiente. | |
| BR302012005545S1 (pt) | Configuração aplicada em recipiente. | |
| BR302012005547S1 (pt) | Configuração aplicada em recipiente. | |
| BR302012005542S1 (pt) | Configuração aplicada em recipiente. | |
| BR302012005544S1 (pt) | Configuração aplicada em recipiente. | |
| BR302013002770S1 (pt) | Configuração aplicada em recipiente. | |
| BR302012005548S1 (pt) | Configuração aplicada em recipiente. | |
| DK2932513T3 (da) | Ferromagnetiske carbonlegemer | |
| IL241401A0 (en) | Modulation of the DNA repair system in the cell to treat malignancies | |
| CL2014002219A1 (es) | Método para separar el renio y el arsénico, y método para la purificación de renio | |
| ITMI20132052A1 (it) | Impianto di alimentazione di carburante e procedimento per farlo funzionare. | |
| CO6880071A2 (es) | Compuestos de antranilamida y sus usos como plaguicidas | |
| CO6880073A2 (es) | Compuestos de antranilamida y sus usos como plaguicidas |